Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-11-10

FDA Approved: CLOZAPINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved Teva's supplemental application for Clozapine (generic) under ANDA090308. This constitutes an approved supplemental modification to the generic pro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clozapine (Clozapine)

Snippet

SUPPL AP for CLOZAPINE (CLOZAPINE)